Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,241.8
-38.3 (-1.17%)

 

  • STI Straits Times Index
    3,241.8
    -38.3 (-1.17%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,590.3
    1.4 (0.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,323.7
    -472.3 (-1.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,069.1
    -26.7 (-0.86%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,909.2
    -174.3 (-0.72%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,237.7
    -7.4 (-0.12%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,252.5
    -10.1 (-0.45%)
    Index delayed 20 minutes
  • XAO XAO
    7,164.6
    -31.7 (-0.44%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 816.9M
  • Value: 324.2M
  • Rise: 45
  • Fall: 214
  • Unch: 560

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
DISA0.003-
Medtecs Intl0.067+0.015
Healthway Med0.041+0.013
Ntegrator Intl0.014-0.001
ThaiBev0.815-0.035
AsiaMedic0.015+0.002
Jiutian Chemical0.021-0.001
QT Vascular0.004-0.001
YZJ Shipbldg SGD1.120-0.020
AusGroup^0.046-0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,388.9 +31.8
HSI 28,323.8 -472.1
HSCEI 11,147.8 -183.7
Jakarta 6,237.9 -7.1
Nikkei 225 23,908.5 -175.0
SSE Comp 3,069.1 -26.7
Shanghai A 3,215.8 -28.0
Shanghai B 258.6 -2.1
PSE Comp 0.0
KOSPI 2,252.5 -10.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NANOVIRICIDES INC NANOVIRICIDES
Updated on 17 Jan 2020 (End of trading day)
Last (USD): 3.360 Change: +0.060 High: 3.526 Remarks: -
Change (%): +1.82 Low: 3.310
Open 3.410 Yesterday's Close 3.3
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 34,473 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13357 Trailing EPS (USD) e -0.12912 NAV (USD) b 0.1447
PE a - Trailing PE f - Price / NAV b 23.2205
Dividend (USD) d - Cash In Hand (USD) g 0.0139 Issued & Paid-up Shares c 3,854,000
Dividend Yield (%) d - Price / Cash In Hand g 241.727 Treasury Shares h -
Beta - 75 Daysi -18.063 R-Squared - 75 Days(%)i 0.65 Market Cap (M) 211.922
Beta - 500 Daysi -2.752 R-Squared - 500 Days (%)i 0.08 Enterprise Value (M) 211.047
Piotroski F Score 1 Exchange Code NNVC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 105.61 Free Float (%) 71.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 19 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NANOVIRICIDES INC NYSE American 211.922 - - 23.2205 -
Industry Biotechnology NYSE American 87.230 - - 3.3148 -
Local Peer PFENEX INC NYSE American 289.407 - - 5.1833 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 235.200 - - -308.5106 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 137.038 - - 4.0358 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 121.138 - - 1.0340 -
Local Peer 22ND CENTURY GROUP INC NYSE American 117.146 - - 2.1182 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 108.505 3.033 2.936 1.1288 -
Local Peer CEL-SCI CORP NYSE American 93.640 - - 18.2397 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 65.406 - - 637.5000 -
Local Peer ISORAY INC NYSE American 48.415 - - 6.9620 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 27.884 - - 1.5378 -
Local Peer ORAGENICS INC NYSE American 22.770 - - 1.5918 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 21.926 - - 2.2061 -
Other Local Peers IBIO INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 143,489.494 17.094 17.787 13.1317 2.317
Global Peer CSL ASX 137,727.155 51.335 51.335 18.4050 0.874
Global Peer GILEAD SCIENCES INC NASDAQ 79,679.147 14.607 29.588 3.8672 3.668
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 60,643.685 28.928 28.288 11.5437 -
Global Peer BIOGEN INC NASDAQ 51,516.191 11.627 9.548 3.6808 -
Global Peer ILLUMINA INC NASDAQ 47,733.840 57.789 49.058 10.7533 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 42,374.657 17.335 19.762 4.0340 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,953.692 88.461 26.101 5.8875 0.678
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,065.632 323.010 17.048 2.4178 -
Other Global Peers SINO BIOPHARM (HKEx), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), EPIZYME INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), HAOHAI BIOTEC (HKEx), REGENXBIO INC (NASDAQ), ALPHAMAB-B (HKEx), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NEXTCURE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), NANOSTRING TECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), KARYOPHARM THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OPKO HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), RADIUS HEALTH INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ASCENTAGE-B (HKEx), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), OMEROS CORP (NASDAQ), KADMON HLDGS INC (NYSE), NANTKWEST INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), PRECISION BIOSCIENCES INC (NASDAQ), AGENUS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), ANAPTYSBIO INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PERSONALIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), CUE BIOPHARMA INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), IVERIC BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), VBI VACCINES INC CDA (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GERON CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DPHARMA (Bursa), ADMA BIOLOGICS INC (NASDAQ), KAMADA (NASDAQ), TELIX PHARMACEUTIC (ASX), LIMINAL BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), AFFIMED N V (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), XOMA CORP (NASDAQ), BBI LIFE SCI (HKEx), GLYCOMIMETICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHIASMA INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SAVARA INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), UNI-BIO GROUP (HKEx), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), NEUROBO PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), ENZO BIOCHEM INC (NYSE), FENNEC PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADURO BIOTECH INC (NASDAQ), IMUGENE LIMITED (ASX), OTONOMY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ORGENESIS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), IMMUTEP LTD (ASX), EQUILLIUM INC (NASDAQ), VERMILLION INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), NEWLINK GENETICS CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), IDERA PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CT ENTERPRISE (HKEx), ONCONOVA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), OCUGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MEMPHASYS LTD (ASX), BIONANO GENOMICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), SIERRA ONCOLOGY INC (NASDAQ), BIONOMICS LTD (ASX), BIOTRON (ASX), UNUM THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), AEVI GENOMIC MEDIC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), TALI DIGITAL LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), EXTRAWELL PHAR (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), RHINOMED LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), CORREVIO PHARMA CORP (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED (ASX), SENESTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PATRYS LIMITED (ASX), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), REGENEUS LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), CYCLACEL PHARMA IN (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), HEAT BIOLOGICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ADALTA LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), OPGEN INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), BIOXYNE LIMITED (ASX), QT Vascular (SGX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), HAO WEN HLDGS (HKEx), PHIO PHARMACEUTICALS CORP (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), SENECA BIOPHARMA INC (NASDAQ), MGRC (Bursa), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), TBG DIAGNOSTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.210
+6.67 %
10 Days --0.040
-1.18 %
20 Days -+0.690
+25.84 %
Medium Term Return 3 Months -+1.380
+69.70 %
6 Months --1.590
-32.12 %
1 Year --1.842
-35.41 %
Long Term Return 2 Years --17.240
-83.69 %
3 Years --18.840
-84.86 %
5 Years --51.040
-93.82 %
Annualised Return Annualised --
-42.70 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.271 - 13.600 Change From 1 Year Low +2.089 % Change From 1 Year Low (%) +164.30
Change From 1 Year High -10.240 % Change From 1 Year High (%) -75.29
2 Years Range 1.271 - 21.580 Change From 2 Years Low +2.089 % Change From 2 Years Low (%) +164.30
Change From 2 Years High -18.220 % Change From 2 Years High (%) -84.43
5 Years Range 1.271 - 68.800 Change From 5 Years Low +2.089 % Change From 5 Years Low (%) +164.30
Change From 5 Years High -65.440 % Change From 5 Years High (%) -95.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Jan 2020 3.410 3.526 3.310 3.360 34,473 -
16 Jan 2020 3.340 3.340 3.065 3.300 35,748 -
15 Jan 2020 3.050 3.240 2.760 3.170 82,943 -
14 Jan 2020 3.200 3.220 2.900 3.150 65,038 -
13 Jan 2020 3.200 3.800 2.760 3.320 111,002 -
10 Jan 2020 3.090 4.240 3.057 3.150 266,540 -
09 Jan 2020 3.000 3.290 2.250 3.290 187,182 -
08 Jan 2020 2.680 2.860 2.543 2.810 128,828 -
07 Jan 2020 2.960 2.960 2.658 2.810 46,679 -
06 Jan 2020 4.000 4.190 2.800 3.180 206,398 -
03 Jan 2020 2.570 3.500 2.410 3.400 93,887 -
02 Jan 2020 2.690 2.690 2.463 2.560 17,788 -
31 Dec 2019 2.600 2.680 2.500 2.510 14,469 -
30 Dec 2019 2.520 2.687 2.517 2.600 15,513 -
27 Dec 2019 2.790 2.790 2.576 2.640 18,776 -
26 Dec 2019 2.670 2.900 2.670 2.727 30,624 -
24 Dec 2019 2.551 2.855 2.551 2.670 50,057 -
23 Dec 2019 2.600 2.900 2.410 2.640 32,568 -
20 Dec 2019 2.900 2.950 2.350 2.670 70,242 -
19 Dec 2019 2.000 2.620 2.000 2.610 48,130 -
18 Dec 2019 2.070 2.120 1.980 2.060 37,346 -
17 Dec 2019 2.150 2.170 1.870 2.080 89,510 -
Summary
Current 2 Weeks
(06 Jan 2020 to 17 Jan 2020)
4.000 4.240 2.250 3.360 1,164,831 -
Previous 2 Weeks
(19 Dec 2019 to 03 Jan 2020)
2.000 4.240 2.000 3.400 392,054 -
4 Weeks from
(20 Nov 2019 to 18 Dec 2019)
2.400 4.240 2.180 2.060 478,313 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.